Trial site
Borbanya Praxis Egeszsegugyi Kft
- 11running trials
- 10closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Obesity12 trials
- Type 2 diabetes8 trials
- Atrial fibrillation3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- High blood pressure1 trial
- Phase
- Phase 316 trials
- Phase 25 trials
- Status
- Active, not recruiting10 trials
- Completed9 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Amgen3 trials
- Pfizer3 trials
- Kailera2 trials
- Amgen Inc.1 trial
- and 8 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
Completed
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Completed
Completed
Completed
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
Site data: ClinicalTrials.govUpdated 17 Nov 2026